Utama › Mieloma Pelbagai › New York › Staten Island
Kajian klinikal Mieloma Pelbagai di Staten Island, NY
13 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Staten Island (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mengambil peserta
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Mengambil pesertaFasa 3
- MSK Monmouth, Middletown · 12 mi jauh
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Mengambil pesertaFasa 3
- MSK Monmouth, Middletown · 12 mi jauh
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Monmouth (Consent only), Middletown · 12 mi jauh
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown · 12 mi jauh
A Dietary Study for People With Multiple Myeloma
Mengambil peserta
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · 12 mi jauh
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Memorial Sloan Kettering Monmouth, Middletown · 12 mi jauh
Kajian Mieloma Pelbagai di bandar lain
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA42 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Baldwin Park, CA23 kajian
- Edison, NJ22 kajian
Kajian lain di Staten Island
- Kanser Payudara40 kajian
- Kanser Paru-paru Bukan Sel Kecil19 kajian
- Kanser Prostat16 kajian
- Leukemia Mieloid Akut14 kajian
- Kanser Paru-paru12 kajian
- Kanser Pundi Kencing11 kajian
- Kanser (semua jenis)11 kajian
- Kanser Endometrium11 kajian
- Kanser Metastatik10 kajian
- Kanser Ovari9 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher9 kajian
- Limfoma8 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.